This story was delivered to Insider Intelligence Digital Health Briefing subscribers earlier this morning.
Insider Intelligence publishes hundreds of insights, charts, and forecasts on the Digital Health industry with the Digital Health Briefing. You can learn more about subscribing here.

Johns Hopkins Medicine (JHM) and Microsoft Azure have teamed up in a five-year deal in which JHM will leverage Microsoft’s AI and analytics tools to facilitate precision medicine breakthroughs. This partnership will expand on JHM’s Precision Medicine Analytics Platform — which was built in 2019 in collaboration with Microsoft to facilitate data collection and analysis and help providers improve patient care plans.

Big tech in HealthcareBusiness Insider Intelligence

AI could help unlock the full potential of precision medicine to improve health outcomes by accelerating providers’ ability to sift through data to tailor treatment options for patients. For context, precision medicine uses genetic and molecular testing to better predict which particular disease treatment will work best for each patient — instead of using a blanket approach to treatment by recommending therapies that don’t take a patient’s unique biology into account. For example, UCSF experts note that precision medicine will take into account factors like genetic predisposition, ethnicity, sex, and age. But in order for precision medicine to be effective, researchers need to be able to sift through and analyze large sets of data.See the rest of the story at Business Insider

See Also:

Proteus Digital Health has filed for bankruptcyHCSC and Epic are rolling out an information exchange platformAkili Interactive lands first FDA clearance for EndeavorRx, its ADHD video game therapeutic

Read more: